Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,204 results
- MONALEESA-2Independent statistical analysis of Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MONARCH 1Independent statistical analysis of A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MONARCH plusIndependent statistical analysis of A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02763566).
- Monitoring of Symptoms and Cognitive Function Using Telehealth: Complete Statistical AnalysisIndependent statistical analysis of Monitoring of Symptoms and Cognitive Function Using Telehealth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03184701).
- Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00549328).
- MORNDIABIndependent statistical analysis of Morbidity in Newly Diagnosed type2 Diabetes in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02002091).
- Morpheus LungIndependent statistical analysis of A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer): primary endpoint results, effect estimate with confidence interval,…
- Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness: Complete Statistical AnalysisIndependent statistical analysis of Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Motorized Continuous Cold Therapy Versus Standard Post-op Icing Protocol for Two Foot and Ankle Procedures: Complete Statistical AnalysisIndependent statistical analysis of Motorized Continuous Cold Therapy Versus Standard Post-op Icing Protocol for Two Foot and Ankle Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Move For Your Health for Older Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Move For Your Health for Older Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05582889).
- MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05780463).
- MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics: Complete Statistical AnalysisIndependent statistical analysis of MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MRI Guided SBRT for Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of MRI Guided SBRT for Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03778112).
- MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval,…
- MSC2015103B in Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of MSC2015103B in Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01453387).
- MSG-01Independent statistical analysis of Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MTBVACIndependent statistical analysis of Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Mu-Opioid Receptor Genetic Polymorphism and Intrathecal Analgesia: Complete Statistical AnalysisIndependent statistical analysis of Mu-Opioid Receptor Genetic Polymorphism and Intrathecal Analgesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00418015).
- MUCINIndependent statistical analysis of Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination: Complete Statistical AnalysisIndependent statistical analysis of Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04722003).
- Multi OIT to Test Immune Markers After Minimum Maintenance Dose: Complete Statistical AnalysisIndependent statistical analysis of Multi OIT to Test Immune Markers After Minimum Maintenance Dose: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03181009).
- Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube: Complete Statistical AnalysisIndependent statistical analysis of Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.: Complete Statistical AnalysisIndependent statistical analysis of Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint…
- Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED): primary endpoint results, effect estimate with confidence interval,…
- Multi-Component Intervention to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV: Complete Statistical AnalysisIndependent statistical analysis of Multi-Component Intervention to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Multicenter Clinical Observation PROMOS®: Complete Statistical AnalysisIndependent statistical analysis of Multicenter Clinical Observation PROMOS®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02280499).
- Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy: primary endpoint results, effect estimate with confidence interval,…
- Multicenter Postmarket Surveillance Registry Evaluating Performance and Long Term Safety of the Presillion Stent: Complete Statistical AnalysisIndependent statistical analysis of Multicenter Postmarket Surveillance Registry Evaluating Performance and Long Term Safety of the Presillion Stent: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.: Complete Statistical AnalysisIndependent statistical analysis of Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only…
- Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide: Complete Statistical AnalysisIndependent statistical analysis of Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant: Complete Statistical AnalysisIndependent statistical analysis of Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Multidisciplinary Support Program in Chronic Hepatitis C: Complete Statistical AnalysisIndependent statistical analysis of Multidisciplinary Support Program in Chronic Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01850745).
- Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery: Complete Statistical AnalysisIndependent statistical analysis of Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Multiple Ascending Dose Study of AMG 598 in Adults With Obesity: Complete Statistical AnalysisIndependent statistical analysis of Multiple Ascending Dose Study of AMG 598 in Adults With Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy: Complete Statistical AnalysisIndependent statistical analysis of Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01677377).
- Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MUSICIndependent statistical analysis of Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04484935).
- Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma: Complete Statistical AnalysisIndependent statistical analysis of Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05723328).
- MV-ZIKA-RSPIndependent statistical analysis of Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04033068).
- MVA-BN-RSV Vaccine Trial: Complete Statistical AnalysisIndependent statistical analysis of MVA-BN-RSV Vaccine Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05238025).
- MYCureIndependent statistical analysis of Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft: Complete Statistical AnalysisIndependent statistical analysis of Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL: Complete Statistical AnalysisIndependent statistical analysis of Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Mylan Insulin Aspart Study: Complete Statistical AnalysisIndependent statistical analysis of Mylan Insulin Aspart Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03760068).
- Myocardial Injury and Quality of Life After COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Myocardial Injury and Quality of Life After COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04794062).